Daniel N. Willis

439 total citations
16 papers, 290 citations indexed

About

Daniel N. Willis is a scholar working on Physiology, Surgery and Sensory Systems. According to data from OpenAlex, Daniel N. Willis has authored 16 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Surgery and 3 papers in Sensory Systems. Recurrent topics in Daniel N. Willis's work include Vascular Malformations and Hemangiomas (2 papers), Neurobiology and Insect Physiology Research (2 papers) and Smoking Behavior and Cessation (2 papers). Daniel N. Willis is often cited by papers focused on Vascular Malformations and Hemangiomas (2 papers), Neurobiology and Insect Physiology Research (2 papers) and Smoking Behavior and Cessation (2 papers). Daniel N. Willis collaborates with scholars based in United States, Australia and Italy. Daniel N. Willis's co-authors include John B. Morris, Michael Ha, Boyi Liu, Sven‐Eric Jordt, Judith T. Zelikoff, Francesca Gany, Sven E. Jordt, Robert J. Hayashi, Frederick S. Huang and Jason L. Blum and has published in prestigious journals such as The Journal of Immunology, The FASEB Journal and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Daniel N. Willis

16 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel N. Willis United States 7 113 68 67 59 32 16 290
Ruobing Han China 8 97 0.9× 16 0.2× 48 0.7× 26 0.4× 18 0.6× 19 378
Matthew G. Thomas United Kingdom 8 71 0.6× 19 0.3× 108 1.6× 63 1.1× 27 0.8× 14 443
Nirav Daphtary United States 15 30 0.3× 273 4.0× 163 2.4× 31 0.5× 182 5.7× 32 628
Howard Maibach United States 10 48 0.4× 54 0.8× 16 0.2× 8 0.1× 8 0.3× 17 398
Niyazi Altıntoprak Türkiye 12 38 0.3× 138 2.0× 84 1.3× 16 0.3× 48 1.5× 25 405
Kimberly Vanhees Netherlands 9 14 0.1× 37 0.5× 135 2.0× 57 1.0× 5 0.2× 13 359
Arunava Ghosh United States 12 30 0.3× 294 4.3× 151 2.3× 40 0.7× 261 8.2× 25 628
Herbert C. Mansmann United States 12 27 0.2× 223 3.3× 58 0.9× 28 0.5× 151 4.7× 45 524
Yanbo Zhen China 5 80 0.7× 60 0.9× 107 1.6× 27 0.5× 31 1.0× 6 323
Raheema Muhammad-Kah United States 11 11 0.1× 168 2.5× 90 1.3× 22 0.4× 28 0.9× 14 311

Countries citing papers authored by Daniel N. Willis

Since Specialization
Citations

This map shows the geographic impact of Daniel N. Willis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel N. Willis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel N. Willis more than expected).

Fields of papers citing papers by Daniel N. Willis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel N. Willis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel N. Willis. The network helps show where Daniel N. Willis may publish in the future.

Co-authorship network of co-authors of Daniel N. Willis

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel N. Willis. A scholar is included among the top collaborators of Daniel N. Willis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel N. Willis. Daniel N. Willis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wu, Ningying, et al.. (2023). Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients. Frontiers in Oncology. 13. 1280587–1280587. 8 indexed citations
2.
Willis, Daniel N., et al.. (2023). Mortality in pediatric oncology and stem cell transplant patients with bloodstream infections. Frontiers in Oncology. 12. 1063253–1063253. 4 indexed citations
3.
Willis, Daniel N., et al.. (2023). Treatment and outcomes of symptomatic hyperammonemia following asparaginase therapy in children with acute lymphoblastic leukemia. Molecular Genetics and Metabolism. 139(3). 107627–107627. 4 indexed citations
4.
Borst, Alexandra J., Abby M. Green, Daniel N. Willis, et al.. (2023). Infectious complications of vascular anomalies treated with sirolimus: A systematic review. Pediatric Blood & Cancer. 71(1). e30758–e30758. 6 indexed citations
5.
Willis, Daniel N., et al.. (2023). Eliminating Central Line Associated Bloodstream Infections in Pediatric Oncology Patients: A Quality Improvement Effort. Pediatric Quality and Safety. 8(3). e660–e660. 2 indexed citations
6.
Borst, Alexandra J., Abby M. Green, Daniel N. Willis, et al.. (2023). Infectious Complications of Vascular Anomalies Treated with Sirolimus: A Systematic Review. 1 indexed citations
7.
Garcia-Ramirez, José, Frederick S. Huang, Daniel N. Willis, et al.. (2022). Failure modes and effects analysis of pediatric I‐131 MIBG therapy: Program design and potential pitfalls. Pediatric Blood & Cancer. 69(12). e29996–e29996. 5 indexed citations
8.
Garcia-Ramirez, José, Frederick S. Huang, Daniel N. Willis, et al.. (2021). Embracing Inpatient Radiopharmaceutical Therapies in Radiation Oncology: An Example With Commissioning Pediatric I-131 MIBG Therapy. International Journal of Radiation Oncology*Biology*Physics. 111(3). e524–e525. 1 indexed citations
9.
Hunter, Matthew F., Sixto García‐Miñáur, Francesca Sperotto, et al.. (2020). Wilms tumor in patients with osteopathia striata with cranial sclerosis. European Journal of Human Genetics. 29(3). 396–401. 10 indexed citations
10.
Willis, Daniel N., Frederick S. Huang, Alexis Elward, et al.. (2020). Clostridioides difficile Infections in Inpatient Pediatric Oncology Patients: A Cohort Study Evaluating Risk Factors and Associated Outcomes. Journal of the Pediatric Infectious Diseases Society. 10(3). 302–308. 14 indexed citations
11.
Willis, Daniel N., et al.. (2014). Toxicity of Gutkha, a Smokeless Tobacco Product Gone Global: Is There More to the Toxicity than Nicotine?. International Journal of Environmental Research and Public Health. 11(1). 919–933. 18 indexed citations
12.
Zelikoff, Judith T., Daniel N. Willis, Heba Degheidy, et al.. (2013). Immune cell profiles in response to silver nanoparticles associated with medical devices (P3357). The Journal of Immunology. 190(Supplement_1). 202.1–202.1. 2 indexed citations
13.
Willis, Daniel N. & John B. Morris. (2012). Modulation of Sensory Irritation Responsiveness by Adenosine and Malodorants. Chemical Senses. 38(1). 91–100. 4 indexed citations
14.
Willis, Daniel N., et al.. (2012). Toxicology of Smokeless Tobacco: Implications for Immune, Reproductive, and Cardiovascular Systems. Journal of Toxicology and Environmental Health Part B. 15(5). 317–331. 34 indexed citations
15.
Willis, Daniel N., Boyi Liu, Michael Ha, Sven‐Eric Jordt, & John B. Morris. (2011). Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants. The FASEB Journal. 25(12). 4434–4444. 147 indexed citations
16.
Willis, Daniel N., et al.. (2010). Role of Metabolic Activation and the TRPA1 Receptor in the Sensory Irritation Response to Styrene and Naphthalene. Toxicological Sciences. 115(2). 589–595. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026